Home Aminos 3'-Methyl-4-dimethylaminoazobenzene

3'-Methyl-4-dimethylaminoazobenzene

CAS No.:
55-80-1
Catalog Number:
AG003JPV
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
25g
>98.0%(T)
1 week
United States
$238
- +
Product Description
Catalog Number:
AG003JPV
Chemical Name:
3'-Methyl-4-dimethylaminoazobenzene
CAS Number:
55-80-1
MDL Number:
MFCD00048014
IUPAC Name:
N,N-dimethyl-4-[(3-methylphenyl)diazenyl]aniline
InChI:
InChI=1S/C15H17N3/c1-12-5-4-6-14(11-12)17-16-13-7-9-15(10-8-13)18(2)3/h4-11H,1-3H3
InChI Key:
LVTFSVIRYMXRSR-UHFFFAOYSA-N
EC Number:
200-243-4
UNII:
SXK3ZE3U4Q
NSC Number:
59783
Properties
Complexity:
267  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
239.142g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
239.322g/mol
Monoisotopic Mass:
239.142g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
28A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.6  
Literature
Title Journal
Changes of blood fluidity in the early hepatopathy in rats. In vivo (Athens, Greece) 20120101
Ortho-aminoazotoluene activates mouse constitutive androstane receptor (mCAR) and increases expression of mCAR target genes. Toxicology and applied pharmacology 20110815
Chronic alcohol consumption prevents 8-hydroxyguanine accumulation in 3'-methyl-4-dimethylaminoazobenzene-treated mouse liver. Biochemical and biophysical research communications 20090918
Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat. Histochemistry and cell biology 20080901
Formate excretion in urine of rats fed dimethylaminoazobenzene-rich diets: the possibility of formate formation from D-lactate. Acta medica Okayama 20080601
FOXA transcription factors determine the amplitude of glucocorticoid induction of tyrosine aminotransferase in mice. Bulletin of experimental biology and medicine 20071101
Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats. Oncology reports 20071001
Activation of constitutive androstane receptor under the effect of hepatocarcinogenic aminoazo dyes in mouse and rat liver. Bulletin of experimental biology and medicine 20070901
[Evolutive characters of oval cells in experimental hepatocarcinogenesis]. Ai zheng = Aizheng = Chinese journal of cancer 20070701
Advanced health assessment in nurse practitioner programs: follow-up study. Journal of professional nursing : official journal of the American Association of Colleges of Nursing 20070101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver. Molecular carcinogenesis 20051201
Role of resistant Drh1 locus in chemical carcinogen-induced hepatocarcinogenesis in rats: analysis with a speed congenic strain. Cancer science 20050301
Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells. Nutrition and cancer 20050101
Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain. Comparative medicine 20040801
Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically induced murine hepatic tumors. International journal of clinical oncology 20040601
Hepatic binding proteins translocating azo dye carcinogen metabolites from cytoplasm into nucleus in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20040301
Detection of a smaller, 32-kDa 8-oxoguanine DNA glycosylase 1 in 3'-methyl-4-dimethylamino-azobenzene-treated mouse liver. Cancer science 20040201
Potential role of p53 mutation in chemical hepatocarcinogenesis of rats. World journal of gastroenterology 20040101
The unknown nuclear protein that decreases HNF3 activity ensures species specificity of action of hepatocarcinogenic amino azo dyes. Doklady. Biochemistry and biophysics 20040101
Modulation of genetic resistance to hepatocarcinogenesis in DRH rats by partial hepatectomy. Cancer letters 20030630
Species specific hepatocarcinogen inhibition of the glucocorticoid induction of tyrosine aminotransferase gene in mouse and rat liver. Biochemistry. Biokhimiia 20030501
[Quantitative analysis of p53 and related genes mRNA in rat hepatocarcinogenesis induced by 3'-Me-DAB]. Ai zheng = Aizheng = Chinese journal of cancer 20030101
Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage. Carcinogenesis 20020101
Effects of gomisin A on the promotor action and serum bile acid concentration in hepatocarcinogenesis induced by 3'-methyl-4-dimethylamino-azobenzene. Biological & pharmaceutical bulletin 19951001
Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver. Japanese journal of cancer research : Gann 19891001
Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion. Japanese journal of cancer research : Gann 19880601
Promotion of hepatocarcinogenesis by suxibuzone in rats initiated with 3'-methyl-4-dimethylaminoazobenzene. Cancer letters 19870701
Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration. Carcinogenesis 19870501
Effect of timing of partial hepatectomy on the induction of preneoplastic liver foci in rats given hepatocarcinogens. Cancer letters 19860701
Promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Toxicologic pathology 19860101
Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine. Cancer letters 19850915
Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1. Japanese journal of cancer research : Gann 19850101
Dose-response studies on promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis. Carcinogenesis 19841201
Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver. Gan 19841001
Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver. Environmental health perspectives 19830401
Promotion of hepatocarcinogenesis in vivo and in vitro. Princess Takamatsu symposia 19830101
Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide. Gan 19820401
Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat. Cancer research 19790101
Properties